Le surprenant potentiel des cellules adultes : Les défis des cellules souches = The surprising potential of adult cellsTURHAN, Ali.Recherche (Paris, 1970). 2002, Num 352, pp 25-28, issn 0029-5671Article

Biologie de la protéine de fusion BCR-ABL : progrès récents = Advances in the study of BCR-ABL fusion proteinTURHAN, Ali.Hématologie (Montrouge). 2002, Vol 8, Num 1, pp 35-45, issn 1264-7527Article

L'imatinib mésylate : une révolution dans le traitement de la leucémie myéloïde chronique = Imatinib mesylate : a major breakthrough in the treatment of chronic myelogenous leukemiaTURHAN, Ali.MS. Médecine sciences. 2003, Vol 19, Num 6-7, pp 667-668, issn 0767-0974, 2 p.Article

Plasticité des cellules souches adultes = Plasticity of adult stem cellsTURHAN, Ali.Hématologie (Montrouge). 2003, Vol 9, Num 2, pp 105-116, issn 1264-7527, 12 p.Article

Leucémie myéloïde chronique : actualités biologiques et thérapeutiques = Chronic myelogenous leukaemia: recent progress in biology and therapeutic strategiesTURHAN, Ali G.Bulletin du cancer. 2005, Vol 92, Num 1, pp 75-82, issn 0007-4551, 8 p.Article

ETUDE DES EFFETS ANTI/APOPTOTIQUES DES ONCOGENES BCR/ABL PAR UTILISATION DES MODELES DE TRANSFORMATION HEMATOPOIETIQUES IN VITRO IMPLICATION POTENTIELLE DES MOLECULES STAT = STUDY OF THE ANTI APOPTOTIC EFFECTS OF BCR/ABL ONCOGENES BY THE USE OF HEMATOPOIETIC MODELS OF TRANSFORMATION IN VITRO POTENTIEL IMPLICATION OF STAT FACTORSAhmed Fadlallah, Mina; Turhan, Ali.1999, 214 p.Thesis

Contrôle de l'hématopoïèse maligne à l'aide de rétrovirus à promoteurs inductibles : Modèle de leucémogénèse par BCR-ABL = Control of malignant hematopoiesis using retroviruses containing inducible promoters : Model of BCR-ABL-induced leukemogenesisDugray, Aymeric; Turhan, Ali.2001, 180 p.Thesis

BCR-ABL-Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia PatientsLEVESCOT, Anaïs; FLAMANT, Stéphane; CHOMEL, Jean-Claude et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 10, pp 2669-2676, issn 0008-5472, 8 p.Article

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable DiseaseROUSSELOT, Philippe; CHARBONNIER, Aude; ESCOFFRE-BARBE, Martine et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 424-430, issn 0732-183X, 7 p.Article

Stratégies thérapeutiques et recommandations pour la prise en charge des patients atteints de leucémie myéloïde chronique = Treatment and monitoring of patients with chronic myeloid leukemiaBORIES, Dominique; DEVERGIE, Agnès; ROUSSELOT, Philippe et al.Hématologie (Montrouge). 2003, Vol 9, Num 6, pp 497-512, issn 1264-7527, 16 p.Article

High level of glutathione-S-transferase π expression in mantle cell lymphomasBENNACEUR-GRISCELLI, Annelise; BOSQ, Jacques; KOSCIELNY, Serge et al.Clinical cancer research. 2004, Vol 10, Num 9, pp 3029-3034, issn 1078-0432, 6 p.Article

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1―BCR-ABL―JAK2 ComplexMIN CHEN; GALLIPOLI, Paolo; LAMBIE, Karen et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 6, pp 405-423, issn 0027-8874, 19 p.Article

Properties of CD34⁺ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylateXIAOYAN JIANG; FORREST, Donna; PANG, Emily et al.Blood. 2010, Vol 116, Num 12, pp 2112-2121, issn 0006-4971, 10 p.Article

Autoimmune protein S activity deficiency following a Q feverBOINOT, Catherine; PLANCHARD, David; GIRAUDEAU, Geneviève et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 255-257, issn 0340-6245, 3 p.Article

L'oncoprotéine Bcr-Abl de 230 kDa induit-elle un syndrome distinct de la leucémie myéloïde chronique ? = Can p230^BCR-ABL myeloproliferative neoplasm be distinguished from chronic myelogenous leukaemia?MAYEUR-ROUSSE, Caroline; AUMERLE, Laureen; SOREL, Nathalie et al.Hématologie (Montrouge). 2009, Vol 15, Num 6, pp 416-423, issn 1264-7527, 8 p.Article

Haemophagocytic histiocyte in a peripheral blood filmSLOMA, Ivan; VINCENT, Hélène; ADDEBBOUS, Amal et al.British journal of haematology. 2014, Vol 165, Num 2, issn 0007-1048, p. 163Article

The role of trapidil on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injuryATICI, Aytug; BOZLU, Gulcin; TURHAN, Ali Haydar et al.Early human development. 2008, Vol 84, Num 4, pp 243-247, issn 0378-3782, 5 p.Article

p210^BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expressionGEAY, Jean-Francois; BUET, Dorothée; YANYAN ZHANG et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2676-2683, issn 0008-5472, 8 p.Article

Platelet-activating factor antagonist (ABT-491) decreases neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injuryBOZLU, Gulcin; ATICI, Aytug; TURHAN, Ali Haydar et al.Brain research. 2007, Vol 1143, pp 193-198, issn 0006-8993, 6 p.Article

STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?VILLALVA, Claire; MARTIN-LANNEREE, Severine; CORTES, Ulrich et al.International journal of cancer (Print). 2011, Vol 128, Num 4, pp 826-838, issn 0020-7136, 13 p.Article

Differential Contributions of STAT5A and STAT5B to Stress Protection and Tyrosine Kinase Inhibitor Resistance of Chronic Myeloid Leukemia Stem/Progenitor CellsCASETTI, Luana; MARTIN-LANNEREE, Séverine; NAJJAR, Imen et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 7, pp 2052-2058, issn 0008-5472, 7 p.Article

BCR-ABL activates STAT3 via JAK and MEK pathways in human cellsCOPPO, Paul; FLAMANT, Stéphane; DE MAS, Véronique et al.British journal of haematology. 2006, Vol 134, Num 2, pp 171-179, issn 0007-1048, 9 p.Article

Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cellsCOPPO, Paul; DUSANTER-FOURT, Isabelle; SAINTENY, Francoise et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 4102-4110, issn 0950-9232, 9 p.Article

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual diseaseCHOMEL, Jean-Claude; BONNET, Marie-Laure; SOREL, Nathalie et al.Blood. 2011, Vol 118, Num 13, pp 3657-3660, issn 0006-4971, 4 p.Article

BCR/ABL promotes dendritic cell-mediated natural killer cell activationTERME, Magali; BORG, Christophe; ZITVOGEL, Laurence et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6409-6417, issn 0008-5472, 9 p.Article